Presented at Molecular Med Tri-Con
MARCH 3, 2020


Navigating the path to developing Companion Diagnostics in Immuno-Oncology can be  challenging.  This presentation will discuss the approach to developing high quality prototype companion Dx IHC assays and their utility in patient selection and potential pivot to a Companion Dx approach.


Ask Your Questions

Have a question related to this presentation? Submit this form and we will get you answers.